| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0008 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |